The company has also revealed its plans for further expansion, announcing pending acquisitions of Eaze, Schwazze, and PharmaCann retail assets in Colorado, with expectations for these transactions to close in the first half of 2026. Vireo closed the quarter with a robust cash position of $122.5 million, indicating its readiness to pursue additional growth opportunities.
Chief Executive Officer John Mazarakis expressed confidence in the company's trajectory, stating, "Fourth quarter performance remained in line with our expectations and reflected pro forma same store sales growth excluding Minnesota of 11.3% and wholesale growth of 55% over the prior year quarter. As we begin the new year, we will continue optimizing all areas of our business while remaining opportunistic with respect to further acquisition-related growth opportunities."
The company’s balance sheet remains strong, with total current assets of $204.1 million and current liabilities of $71.6 million, positioning Vireo well for future endeavors. The management team is focused on integrating recent acquisitions and realizing synergies, which are expected to enhance operational efficiency and profitability.
Vireo's strategic outlook includes a commitment to maintaining its growth momentum through targeted acquisitions and operational improvements. The company will host a conference call on March 17, 2026, at 8:00 a.m. ET to discuss these results in detail and provide further insights into its strategic direction.
